Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.54 |
| ▸ | AGXT | P21549 | 2/20 | 0.54 |
| ▸ | MAOB | P27338 | 4/20 | 0.48 |
| ▸ | CMA1 | P23946 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.46 |
| ▸ | MMP13 | P45452 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21875855 | 0.94 | IDO1 (0.61) | IDO1AGXTMAOBCMA1TAAR1 | |
| SCHEMBL29648388 | 0.85 | TSHR (0.51) | IDO1AGXTMAOBTAAR1MMP13 | |
| SCHEMBL8210094 | 0.83 | TSHR (0.46) | — | |
| SCHEMBL11916847 | 0.82 | CYP3A4 (0.50) | — | |
| SCHEMBL5167661 | 0.81 | IDO1 (0.51) | IDO1MAOBTAAR1 | |
| SCHEMBL21875857 | 0.81 | IDO1 (0.57) | IDO1AGXTMAOBCMA1TAAR1 | |
| SCHEMBL4801868 | 0.81 | IDO1 (0.50) | IDO1AGXTMAOBCMA1TAAR1 | |
| SCHEMBL5521298 | 0.80 | IDO1 (0.48) | IDO1AGXTMAOB | |
| SCHEMBL30323683 | 0.79 | CMA1 (0.47) | IDO1AGXTCMA1TAAR1MMP13 | |
| SCHEMBL4237467 | 0.79 | CMA1 (0.47) | IDO1AGXTCMA1TAAR1MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101475451-B | Method for synthesizing trans-resveratrol | UNIV NANJING NORMAL | 2011-10-26 | — | — | CN | claimed |
| CN-101475451-A | Method for synthesizing trans-resveratrol | UNIV NANJING NORMAL (CN) | 2009-07-08 | — | — | CN | claimed |
| CN-105541569-A | Synthesis method of 1-benzyloxy-2-[2-(3-methoxyphenyl)vinyl]benzene | SUZHOU CHENGHE PHARMACEUTICAL & CHEMICAL CO LTD | 2016-05-04 | — | — | CN | disclosed |
| CN-105541566-A | Method for synthesizing 1-benzyloxy-2-[2-(3-methoxyphenyl)vinyl]benzene | SUZHOU CHENGHE PHARMACEUTICAL & CHEMICAL CO LTD | 2016-05-04 | — | — | CN | disclosed |
| CN-105541564-A | New method for synthesizing 1-benzyloxy-2-[2-(3-methoxyphenyl)vinyl]benzene | SUZHOU CHENGHE PHARMACEUTICAL & CHEMICAL CO LTD | 2016-05-04 | — | — | CN | disclosed |
| CN-105541565-A | Method for preparing 1-benzyloxy-2-[2-(3-methoxyphenyl)vinyl]benzene | SUZHOU CHENGHE PHARMACEUTICAL & CHEMICAL CO LTD | 2016-05-04 | — | — | CN | disclosed |
| CN-105503950-A | Method for synthesizing m-methoxybenzyl diphenylphosphine oxide | TAICANG KASITEMU NEW MAT CO LTD | 2016-04-20 | — | — | CN | disclosed |
| CN-105503954-A | Synthetic method of m-methoxy benzyl diphenyl phosphine oxide | SUZHOU CHENGHE PHARMACEUTICAL & CHEMICAL CO LTD | 2016-04-20 | — | — | CN | disclosed |
| CN-105503953-A | Method for synthesizing 3-methoxybenzyl diphenylphosphine oxide | SUZHOU CHENGHE PHARMACEUTICAL & CHEMICAL CO LTD | 2016-04-20 | — | — | CN | disclosed |
| CN-105503951-A | Method for one-step synthesis of meta-methoxy benzyl diphenyl phosphine oxide | TAICANG KASITEMU NEW MAT CO LTD | 2016-04-20 | — | — | CN | disclosed |
| CN-105503952-A | Method for conveniently preparing m-methoxyl benzyl diphenylphosphine oxide | SUZHOU CHENGHE PHARMACEUTICAL & CHEMICAL CO LTD | 2016-04-20 | — | — | CN | disclosed |
| CN-105440075-A | Method for preparing m-methoxy benzyldiphenylphosphine | TAICANG CASS TATUM NEW MAT CO LTD | 2016-03-30 | — | — | CN | disclosed |
| CN-105439828-A | Method for synthesizing 1-benzyloxy-2-[2-(3-methoxyphenyl) vinyl]benzene | SUZHOU CHENGHE PHARMACEUTICAL & CHEMICAL CO LTD | 2016-03-30 | — | — | CN | disclosed |
| CN-105418677-A | Preparation method for 3-methoxybenzyl diphenylphosphine oxide | SUZHOU CHENGHE PHARMACEUTICAL & CHEMICAL CO LTD | 2016-03-23 | — | — | CN | disclosed |
| CN-101475451-B | Method for synthesizing trans-resveratrol | UNIV NANJING NORMAL | 2011-10-26 | — | — | CN | disclosed |
| CN-101875600-A | Synthesis method for industrially producing resveratrol | CHENGDU XINJI TECHNOLOGY CO LTD | 2010-11-03 | — | — | CN | disclosed |
| CN-101475451-A | Method for synthesizing trans-resveratrol | UNIV NANJING NORMAL (CN) | 2009-07-08 | — | — | CN | disclosed |
| US-20090170901-A1 | Benzoyl Urea Derivatives | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 2009-07-02 | — | — | US | disclosed |
| EP-1771429-A1 | NEW BENZOYL UREA DERIVATIVES | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 2007-04-11 | — | — | EP | disclosed |
| WO-2006010966-A1 | NEW BENZOYL UREA DERIVATIVES | Richter Gedeon Vegyészeti Gyár Rt. (HU) | 2006-02-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090170901-A1 | Benzoyl Urea Derivatives | OPRM1, GRIN2C, GRIN3A | IDO1 2101/4885AGXT 2703/4885MAOB 399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.